Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes.

Front Endocrinol (Lausanne) · 2022 · PMC8882829 · PMID 35237235

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Either angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) were used at a higher rate in patients with prediabetes while dihydropyridine calcium channel blocker (DHP-CCB) was used at a higher rate in participants with normoglycemia; however, the difference did not reach statistical significance ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.